Glycoprofile Comparison of the SARS-CoV-2 Spike Proteins Expressed in CHO and HEK Cell Lines
Molecular Biotechnology · 2025
DOI: 10.1007/s12033-024-01288-2 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Molecular Biotechnology, 2025. Verfasst von Helen L Wright und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Chemical, Materials and Biological Engineering, University of Sheffield, Mappin St., Sheffield, S1 3JD, UK. Hauptthemen laut MEDLINE: Spike Glycoprotein, Coronavirus, SARS-CoV-2. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 72 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Biotechnology and Biological Sciences Research Council, Sheffield Teaching Hospitals NHS Foundation Trust.
Abstract (Originalsprache)
Coronavirus SARS-CoV-2 spike protein remains a key focus of research due to a continued need for diagnostic and therapeutic tools to monitor and respond to new variants. Glycosylation of the spike protein is critical for the protein’s functions in viral attachment and host cell entry. For scalable and cost-effective production of the spike protein, expression system-driven divergence in glycosylation patterns on recombinant spike proteins needs to be fully understood. This study assessed the N -glycosylation profiles of a full-length trimeric spike protein expressed in either Human Embryonic Kidney (HEK Expi293F) or Chinese Hamster Ovary (CHO-S) cells. Glycopeptide analysis was performed using a tandem mass spectrometry workflow and BioPharma $${\hbox {Finder}}^{\textrm{TM}}$$ Finder TM incorporating HEK and CHO glycan databases for protein characterisation. The results outline important differences in the variety and types of N -glycan generated by the two cell lines across the 22 known N -glycosylation sites of the spike protein. A notable increase in terminal sialylation, as well as the presence of the potentially immunogenic N -glycolylneuraminic acid at a functionally key N -glycosylation site, was observed in the CHO-S derived spike protein. With the potential for the relatively vast and more complex CHO glycan repertoire (182 glycans relative to 39 human glycans) to produce functional implications with CHO-S expressed spike protein, this study adds valuable knowledge to aid Quality by Design approaches and enable Multi Attribute Monitoring of specific N -glycosylation sites for proteoform analyses. This can further inform antigen development with future variants in order to devise updated diagnostic tests and therapeutic vaccine designs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Chemical, Materials and Biological Engineering, University of Sheffield, Mappin St., Sheffield, S1 3JD, UK.
- School of Biosciences, University of Sheffield, Western Bank, Sheffield, S10 2TN, UK.
- School of Chemical, Materials and Biological Engineering, University of Sheffield, Mappin St., Sheffield, S1 3JD, UK. j.pandhal@sheffield.ac.uk.
Förderung
- Biotechnology and Biological Sciences Research Council
- Sheffield Teaching Hospitals NHS Foundation Trust
Zitieren
APA
Wright, H. L., Evans, C., Jackson, P. J., James, D. C., Tee, K. L., Wong, T. S., Dickman, M. J., & Pandhal, J. (2025). Glycoprofile Comparison of the SARS-CoV-2 Spike Proteins Expressed in CHO and HEK Cell Lines. Molecular Biotechnology. https://doi.org/10.1007/s12033-024-01288-2
Vancouver
Wright HL, Evans C, Jackson PJ, James DC, Tee KL, Wong TS, et al. Glycoprofile Comparison of the SARS-CoV-2 Spike Proteins Expressed in CHO and HEK Cell Lines. Molecular Biotechnology. 2025. doi:10.1007/s12033-024-01288-2
BibTeX
@article{Wright2025,
author = {Wright, Helen L and Evans, Caroline and Jackson, Philip J and James, David C and Tee, Kang Lan and Wong, Tuck Seng and Dickman, Mark J and Pandhal, Jagroop},
title = {Glycoprofile Comparison of the SARS-CoV-2 Spike Proteins Expressed in CHO and HEK Cell Lines},
journal = {Molecular Biotechnology},
year = {2025},
doi = {10.1007/s12033-024-01288-2}
}
EUVIMED